Ethylene Glycol, min 99%, for synthesis, 1L, plastic packaging.

5-Bromo-4-methylbenzo[d]thiazol-2-amine, 97.0%, 5g

(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl)glycylglycyl-L-phenylalanylglycine, 98%, 100mg

(S)-3-Bromo-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

3,4-Dihydro-5-hydroxy-1(2H)-isoquinolinone, 95.0%, 100mg

2-Chloro-6-methoxybenzothiazole, 97.0%, 25g

3-Amino-5-(4-methoxyphenyl)thiophene-2-carboxylic acid methyl ester, 95.0%, 5g

Allylsuccinic anhydride, 97.0%, 250mg

4-Nitrophenyl beta-D-Glucuronide [Substrate for beta-Glucuronidase]>98.0%(HPLC)100mg

(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methanol, 95.0%, 10g

Hematoxylin solution acc. to Gill II, 500 ml, glass

1-(3-Amino-5-(benzyloxy)-2-hydroxyphenyl)ethan-1-one, 98%, 100mg

1-Bromo-5-chloro-2-iodo-3-methoxybenzene, 98%, 5g